Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By boosting these receptors, https://nanavfgk717674.losblogos.com/35301295/tirzepatide-a-promising-new-treatment-for-obesity